Stocks · Healthcare · Medical - Devices
Myomo, Inc. MYO
$1.63 +1.24% Close, Oct 2, 2026 · AMEX · Market cap $63.0M
Strong trendHigh risk
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Over the past year the stock returned +78.1%, ahead of the S&P 500 by 63.0 percentage points.
- The stock is in an uptrend: above its 200-day average for 53 trading days, with the 50-day average above the 200-day.
- Earnings beat analyst estimates in each of the last 4 quarters (average surprise over the last four: +20.7%).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 43%
- Revenue growth, 3-year CAGRTop 18%
- Revenue growth accelerationBottom 47%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 29%
- Gross marginTop 45%
- Operating marginBottom 40%
- Accruals (lower is better)Top 13%
- Interest coverBottom 38%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 32%
- Free-cash-flow yieldBottom 31%
- EBITDA / enterprise valueBottom 31%
- Sales / enterprise valueTop 20%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 32%
- 6-month returnTop 4%
- 1-year return vs S&P 500Top 20%
- Distance from 52-week highTop 22%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 23%
- Consecutive EPS beatsTop 19%
- Share of analysts rating BuyTop 31%
- Upside to consensus price targetTop 35%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 7%
- Maximum drawdown, 3 yearsBottom 14%
- Beta vs S&P 500 (lower is better)Bottom 23%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 6.7% | 6.1% | ↓ |
| Gross margin | 69.2% | 68.4% | ↓ |
| Operating margin | -22.8% | -27.1% | ↓ |
| FCF margin | -31.4% | -20.4% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 6.1% | 6.7% | ↓ | Bottom 43% |
| Gross margin | 68.4% | 69.2% | ↓ | Top 45% |
| Operating margin | -27.1% | -22.8% | ↓ | Bottom 40% |
| Net margin | -33.5% | -22.9% | ↓ | — |
| Free-cash-flow margin | -20.4% | -31.4% | ↑ | — |
| Return on invested capital | -45.2% | — | Bottom 29% | |
| Revenue growth, 3-year CAGR | 38.1% | — | Top 18% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -20.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -36.0 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -6.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.39%
- Shareholder yield
- 0.39%
- Share count change, 1 year
- +2.7%
- Share count change, 3-year CAGR
- +15.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 4
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +20.7%
- Average 2-day reaction, last 8
- +0.4%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $3.45
- Target vs current price
- +111.7%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 88%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +28.6% | -1.9% | +39.8% | +32.4% | — |
| May 7, 2026 | +25.0% | +2.2% | -4.7% | +51.2% | +21.9% |
| Mar 9, 2026 | +11.1% | +1.3% | -13.0% | -12.3% | +32.3% |
| Nov 10, 2025 | +18.2% | +7.4% | -4.4% | +26.5% | -9.4% |
| Aug 11, 2025 | +0.0% | -3.8% | -46.7% | -45.7% | -52.6% |
| May 7, 2025 | +0.0% | +1.5% | -33.1% | -39.6% | -60.8% |
| Mar 10, 2025 | +50.0% | -9.3% | +12.8% | -5.4% | -37.4% |
| Nov 6, 2024 | -28.6% | +5.6% | +26.0% | +35.1% | +59.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.07 | -$0.10 | +28.6% | $11.7M |
| May 7, 2026 | -$0.09 | -$0.12 | +25.0% | $10.1M |
| Mar 9, 2026 | -$0.08 | -$0.09 | +11.1% | $11.4M |
| Nov 10, 2025 | -$0.09 | -$0.11 | +18.2% | $10.1M |
| Aug 11, 2025 | -$0.11 | -$0.11 | +0.0% | $9.7M |
| May 7, 2025 | -$0.08 | -$0.08 | +0.0% | $9.8M |
| Mar 10, 2025 | -$0.01 | -$0.02 | +50.0% | $12.1M |
| Nov 6, 2024 | -$0.03 | -$0.02 | -28.6% | $9.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1.66× | — | — | Top 20% |
| Free-cash-flow yield | -14.03% | — | — | Bottom 31% |
| Earnings yield | -20.88% | — | — | Bottom 32% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 12
- Days above the 200-day average
- 53
- 50-day average slope (20 days)
- +13.1%
- 200-day average slope (20 days)
- +5.7%
- Distance from 50-day average
- +15.0%
- Distance from 200-day average
- +56.2%
- RSI (14)
- 59.9
- Relative volume
- 0.46×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 107.4%
- Volatility vs own 5-year history
- 63th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.74
- Correlation with S&P 500
- 0.31
- Current drawdown from 1-year high
- -12.4%
- Maximum drawdown, 3 years
- -90.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 16, 2021 | Jan 12, 2023 | -97.8% | 481 days | Not yet recovered |
| Nov 24, 2020 | Dec 30, 2020 | -17.7% | 24 days | 6 days (Jan 8, 2021) |
| Jan 26, 2021 | Jan 29, 2021 | -14.3% | 3 days | 6 days (Feb 8, 2021) |
| Nov 11, 2020 | Nov 12, 2020 | -10.7% | 1 days | 7 days (Nov 23, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $63.0M
- EPS, diluted (TTM)
- -$0.34
- Revenue (TTM)
- $43.3M
- 52-week range
- $0.61 – $1.89
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $13.9M | $15.6M | $19.2M | $32.6M | $40.9M |
| Gross profit | $10.3M | $10.3M | $13.2M | $23.2M | $26.9M |
| Operating income | -$10.3M | -$10.7M | -$8.2M | -$6.2M | -$14.4M |
| Net income | -$10.4M | -$10.7M | -$8.1M | -$6.2M | -$15.6M |
| EPS (diluted) | -$1.78 | -$1.52 | -$0.28 | -$0.16 | -$0.37 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.2M | $12.1M | $9.8M | $9.7M | $10.1M | $11.4M | $10.1M | $11.7M |
| Net income | -$966,409 | -$260,081 | -$3.5M | -$4.6M | -$3.7M | -$3.8M | -$3.0M | -$4.0M |
| EPS (diluted) | -$0.03 | -$0.01 | -$0.08 | -$0.11 | -$0.09 | -$0.09 | -$0.07 | -$0.09 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$9.5M | -$10.2M | -$6.2M | -$3.3M | -$14.5M |
| Capital expenditure | -$326,462 | -$111,793 | -$145,816 | -$1.4M | -$1.7M |
| Free cash flow | -$9.9M | -$10.3M | -$6.3M | -$4.7M | -$16.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $13.2M | $376,858 | $9.7M | $20.4M | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $13.5M
- Total assets
- $35.3M
- Total liabilities
- $29.5M
- Total debt
- $20.1M
- Net debt
- $8.9M
- Shareholders’ equity
- $5.8M
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 1,197,315
- Days to cover
- 3.57
- Change vs previous report
- +0.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jan 31, 2020
- 1-for-30